Zhiping Mi, M.D.
See information for Patients. Viewing information for Researchers.
Contact
University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 645
Rochester, New York 14642
Office: 585 275-6665 (primary)
Dr. Mi's primary research interests are: Neural Crest Tumors, Oxidative Injury in Nervous System, and Neurodegenerative Diseases.
Current Appointments
- Research Assistant Professor - Department of Pediatrics (SMD)
| Education | ||
|---|---|---|
| MS Physiology | Shanxi Medical University | 1989 |
| MD Medicine | Shanxi Medical University | 1984 |
| Recent Journal Articles |
|---|
| Showing the 5 most recent journal articles. (17 available) |
| Rogers D; Nylander KD; Mi Z; Hu T; Schor NF. "Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy." Cancer chemotherapy and pharmacology. 2008; 62(4):699-706. Epub 2008 Mar 13. |
| Korade Z; Mi Z; Portugal C; Schor NF. "Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain." Neurobiol of Aging 28 (2007): 1522-1531. |
| Korade Z; Mi Z; Portugal C; Schor NF. "Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain." Neurobiology of aging. 2007; 28(10):1522-31. Epub 2006 Aug 02. |
| ZP Mi, ZK Mirnics, NF Schor. "Bcl-2 Overexpression Disrupts the Morphology of PC12 Cells through Reduced ERK Activation". Molecular Brain Research 1112 (2006): 46-55. |
| Mi Z; Hong B; Mirnics ZK; Tyurina YY; Kagan VE; Liang Y; Schor NF. "Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2." Cancer chemotherapy and pharmacology. 2006; 57(3):357-67. Epub 2005 Jul 05. |
